Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease.
Orphanet J Rare Dis
; 17(1): 289, 2022 07 23.
Article
in En
| MEDLINE
| ID: mdl-35871071
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Lung Diseases, Interstitial
/
COVID-19
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Child
/
Humans
Language:
En
Year:
2022
Type:
Article